02/09/2020
WAR ON CORONAVIRUS
Covid-19 vaccine in last stage
of testing, to cost Sh300 per
dose
An individual might need one or two injections
for a year-long protection against the virus.
by Taboola
In Summary
• Gavi has already listed Kenya among the 92
countries that will benefit from its ongoing
negotiations with different manufacturers.
• WHO says more than 160 candidate vaccines
are in progress around the world, with 29 in
human trials.
LEADING BY EXAMPLE Mombasa Governor
Hassan Joho undergoes a test for
Covid-19 in Likoni to encourage residents
to also get tested.
Image: CHARLES MGHENYI
A leading Covid-19 vaccine candidate
will cost Kenya Sh300 per dose, one
manufacturer has said.
An individual might need one or two
injections for a year-long protection
against the coronavirus.
The ceiling price was given by the
world's biggest vaccines manufacturer,
Serum Institute of India, who have been
contracted to supply developing
countries with the University of Oxford-
Astrazeneca vaccine as soon as it is
prequalified this year or in 2021.
SII has been contracted by Gavi, the
Geneva-based alliance that is leading a
global initiative to secure Covid-19
vaccines for developing countries.
Gavi has already listed Kenya among the
92 countries that will benefit from its
ongoing negotiations with different
manufacturers.
SII said it set a ceiling price of $3
(Sh300) per dose because of investments
by Gavi partners such as the Bill &
Melinda Gates Foundation.
SII has so far been contracted to
manufacture the AstraZeneca candidate,
which is in the last stages of testing, and
another by US biotech firm Novavax.
The World Health Organization says
more than 160 candidate vaccines are in
progress around the world, with 29 in
human trials.
“Too many times we’ve seen the most
vulnerable countries left at the back of
the queue when it comes to new
treatments, new diagnostics and new
vaccines,” Dr Seth Berkley, CEO of Gavi,
said in a statement.
“This new collaboration is an important
step in ou
